GlassScriptPhysician profile
Luis Baez Diaz
NPI 1467455535
$5,774.56
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,729 · 2020: $2,439 · 2021: $550 · 2022: $10.85 · 2023: $22.55 · 2024: $22.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,550.40 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $478.64 | 2019-2021 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $436.03 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $377.42 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $363.96 | 2019-2021 | |
| Genentech USA, INC. | $315.14 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $301.41 | 2019-2021 | |
| Clovis Oncology, INC. | $218.79 | 2019-2020 | |
| Genzyme Corporation | $217.83 | 2019-2020 | |
| Amgen INC. | $185.74 | 2019-2021 | |
| Pbg Puerto Rico LLC | $152.43 | 2019-2020 | |
| Eisai INC. | $145.50 | 2019-2020 | |
| Abbvie INC. | $140.05 | 2019 | |
| Puma Biotechnology, INC. | $138.72 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $88.94 | 2019 | |
| Sanofi-Aventis U.S. LLC | $74.91 | 2019-2021 | |
| Pfizer Pharmaceuticals LLC | $66.73 | 2019 | |
| Pfizer INC. | $58.20 | 2019-2020 | |
| Celgene Corporation | $50.52 | 2019 | |
| Seagen INC. | $44.47 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.77 | 2020 | |
| Rigel Pharmaceuticals, INC. | $38.74 | 2019 | |
| Taiho Oncology, INC. | $36.34 | 2019-2020 | |
| Gilead Sciences, INC. | $24.66 | 2021 | |
| Spectrum Pharmaceuticals INC. | $22.28 | 2019 | |
| Adc Therapeutics America, INC. | $21.84 | 2021 | |
| Beigene USA, INC. | $16.05 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Baez Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.